Saroglitazar for the treatment of NASH: the PPAR story goes on!
Sign Up to like & getrecommendations! Published in 2021 at "Hepatology"
DOI: 10.1002/hep.32024
Abstract: Despite intensive research, no drug has to date been approved for the management of NAFLD, and many clinical trials have failed, including some recent large phase 3 trials. This has in part to do with… read more here.
Keywords: saroglitazar treatment; treatment nash; story goes; nash ppar ... See more keywords